BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
Copyright: ©Author(s) 2026.
World J Methodol. Sep 20, 2026; 16(3): 117065
Published online Sep 20, 2026. doi: 10.5662/wjm.117065
Table 2 Oral anticoagulant adherence
Ref.
Intervention/trial name
Adherence metric
Follow-up
Key finding
Interpretation
Studies reporting a positive effect on adherence
Yoon et al[32], 2024ADHERE-app (Alerts + monitoring)Pill count (≥ 95% threshold)6 monthsProportion with adequate adherence (≥ 95%) significantly higher in intervention (73.9% vs 61.0%; P = 0.007)Intervention increased the likelihood of achieving high adherence
Hsieh et al[35], 2021Web-based integrated programMARS (self-report scale)6 monthsSignificantly greater improvement in adherence vs control over time (GEE analysis, P = 0.001)Sustained improvement in self-reported adherence
Xu et al[36], 2024Alfalfa app (education + consultation)MMAS-8 (self-report scale)3 monthsMedication compliance significantly higher at 1 and 3 months (all P < 0.05)Short-term improvement in self-reported adherence
Guo et al[31], 2017mAFA pilot (mAF app)3-item adherence estimator3 monthsDrug adherence significantly better at 1 and 3 months (all P < 0.05)Early improvement in adherence with integrated app
Magnani et al[37], 2025Rural AF intervention (agent + monitor)3-item self-report instrument4 and 8 monthsSelf-reported adherence significantly higher (OR = 1.89)Positive subjective effect, despite no objective difference
Guo et al[30], 2020mAFA-II (dynamic management)OAC usage/uptake12 monthsOAC use increased in intervention (63.4% to 70.2%) but decreased in control (P < 0.001)Intervention improved OAC persistence at a population level
Studies reporting no significant difference in objective adherence
Yoon et al[32], 2024ADHERE-app (alerts + monitoring)Pill count (continuous median)6 monthsNo difference in median adherence (98% vs 97.5%; P = 0.15).High baseline adherence in both groups limited improvement
Turakhia et al[33], 2021SmartADHERE (blended support)PDC6 monthsNo difference in mean PDC (0.86 vs 0.88; P = 0.62) or PDC ≥ 80%Exceptionally high adherence in control group (“ceiling effect”)
Tran et al[38], 2022BOAT-OAR (ECG + organizer)Pill Count (median)5.9 monthsNo difference in median compliance (100% vs 99.7%; P = 0.247)Near-perfect adherence in both groups
Magnani et al[37], 2025Rural AF intervention (agent + monitor)PDC12 monthsNo difference in 12-month PDC (median 0.97 both groups)Objective measure did not confirm self-reported benefits


Write to the Help Desk